JGUA

John G. Ullman & Associates Portfolio holdings

AUM $824M Turnover 14.14%
1-Year Est. Return 78.19%
This Fund
S&P 500
This Quarter Est. Return
+5.35%
1 Year Est. Return
+78.19%
3 Year Est. Return
+156.18%
5 Year Est. Return
+168.38%
10 Year Est. Return
+388.18%
AUM
$531M
AUM Growth
+$11.2M
Cap. Flow
-$11.3M
Cap. Flow %
-2.13%
Top 10 Hldgs %
33.37%
Holding
161
New
13
Increased
36
Reduced
86
Closed
16
Avg Time Held
1.2 years
Top 10 Avg Time Held
1.3 years
Top 20 Avg Time Held
1.3 years

Top Buys

Rank Stock Value
1
OGE icon
OGE Energy
OGE
+$2.24M
2
HAL icon
Halliburton
HAL
+$2.23M
3
CBI
Chicago Bridge & Iron Nv
CBI
+$2.21M
4
FCX icon
Freeport-McMoran
FCX
+$2.04M
5
BKNG icon
Booking.com
BKNG
+$1.78M

Sector Composition

Rank Sector Weight
1 Healthcare 25.33%
2 Industrials 21.78%
3 Technology 17.67%
4 Utilities 9.91%
5 Energy 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
JNJ icon
1
Johnson & Johnson
JNJ
$612B
$29.3M 5.52%
280,321
-8,616
-3% -$908K
2013 Q2
6 quarters
GLW icon
2
Corning
GLW
$121B
$23.2M 4.38%
1,013,359
-38,480
-4% -$784K
2013 Q2
6 quarters
XOM icon
3
ExxonMobil
XOM
$728B
$21.5M 4.05%
232,365
+11,114
+5% +$1.04M
2013 Q2
6 quarters
EMR icon
4
Emerson Electric
EMR
$89.9B
$19.1M 3.59%
308,873
+27,425
+10% +$1.72M
2013 Q2
6 quarters
KO icon
5
Coca-Cola
KO
$395B
$15.9M 3%
377,671
-4,325
-1% -$185K
2013 Q2
6 quarters
INTC icon
6
Intel
INTC
$519B
$15.5M 2.92%
427,151
-11,326
-3% -$394K
2013 Q2
6 quarters
PLL icon
7
DELISTED
PALL CORP
PLL
$14.3M 2.7%
141,652
-444
-0.3% -$41K
2013 Q2
6 quarters
PFE icon
8
Pfizer
PFE
$166B
$13.3M 2.51%
451,351
+3,162
+0.7% +$90.7K
2013 Q2
6 quarters
BMY icon
9
Bristol-Myers Squibb
BMY
$121B
$13.1M 2.48%
222,736
-2,516
-1% -$142K
2013 Q2
6 quarters
SLB icon
10
SLB Ltd
SLB
$72B
$11.8M 2.23%
138,595
+14,560
+12% +$1.34M
2013 Q2
6 quarters
MRK icon
11
Merck
MRK
$364B
$11.5M 2.17%
212,434
-2,594
-1% -$145K
2013 Q2
6 quarters
GXP
12
DELISTED
Great Plains Energy Incorporated
GXP
$10.5M 1.97%
368,695
-7,780
-2% -$205K
2013 Q2
6 quarters
GSK icon
13
GSK
GSK
$95.9B
$10.1M 1.9%
188,904
+11,548
+7% +$646K
2013 Q2
6 quarters
GVA icon
14
Granite Construction
GVA
$4.79B
$9.88M 1.86%
259,877
+4,125
+2% +$146K
2013 Q2
6 quarters
BCE icon
15
BCE
BCE
$18.3B
$9.13M 1.72%
199,158
+1,675
+0.8% +$75.2K
2013 Q2
6 quarters
HON icon
16
Honeywell
HON
$65.8B
$8.72M 1.64%
97,083
-1,860
-2% -$160K
2013 Q2
6 quarters
IBM icon
17
IBM
IBM
$215B
$8.57M 1.61%
55,908
-3,505
-6% -$558K
2013 Q2
6 quarters
CSCO icon
18
Cisco
CSCO
$448B
$8.53M 1.61%
306,635
-4,700
-2% -$121K
2013 Q2
6 quarters
IDA icon
19
Idacorp
IDA
$7.92B
$8.33M 1.57%
125,870
-6,875
-5% -$422K
2013 Q2
6 quarters
GE icon
20
GE Aerospace
GE
$319B
$8.26M 1.56%
68,234
+12,837
+23% +$1.58M
2013 Q2
6 quarters
AZTA icon
21
Azenta
AZTA
$1.63B
$8.03M 1.51%
630,092
-4,125
-0.7% -$48K
2013 Q2
6 quarters
LNN icon
22
Lindsay Corp
LNN
$1.14B
$7.24M 1.36%
84,478
+300
+0.4% +$25.5K
2013 Q2
6 quarters
MSFT icon
23
Microsoft
MSFT
$3.96T
$6.41M 1.21%
138,005
-1,550
-1% -$72.8K
2013 Q2
6 quarters
OTTR icon
24
Otter Tail
OTTR
$3.75B
$6.4M 1.21%
206,678
+2,250
+1% +$66.4K
2014 Q1
3 quarters
NEE icon
25
NextEra Energy
NEE
$163B
$6.18M 1.16%
232,640
-560
-0.2% -$14.1K
2013 Q2
6 quarters

Similar funds

John G. Ullman & Associates's Q4 2014 Portfolio in Review

As of Q4 2014, John G. Ullman & Associates held 161 positions worth $531M, up 2.2% from $520M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

John G. Ullman & Associates's Q4 2014 filing shows 13 new, 36 increased, 86 reduced and 16 closed positions. Its largest new stake was Halliburton: 45,734 shares worth $1.8M. The largest sale was Procter & Gamble, an estimated $3.77M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 25% a quarter earlier, followed by Industrials and Technology.

  • John G. Ullman & Associates's largest Q4 2014 buy was Halliburton: 45,734 shares worth $1.8M.
  • John G. Ullman & Associates added most to OGE Energy in Q4 2014, an estimated $2.24M increase.
  • John G. Ullman & Associates's biggest Q4 2014 reduction was Apple, cutting an estimated $3.52M.
  • John G. Ullman & Associates fully exited Procter & Gamble in Q4 2014, selling an estimated $3.77M.
  • John G. Ullman & Associates's ten largest holdings make up 33% of its $531M portfolio in Q4 2014.
  • John G. Ullman & Associates opened 13 new positions and closed 16 in Q4 2014.
  • John G. Ullman & Associates's portfolio value rose 2.2% quarter-over-quarter to $531M.

Based on John G. Ullman & Associates's 13F filing for Q4 2014, filed 26 Jan 2015.